Summit Therapeutics
Pioneering next-generation antibiotics for enhanced patient care and value in healthcare.
Founded 2003
51-200 employees
Select
Total: $1.44B
Biotechnology, Health Care +2
General Information
Get notified when Summit Therapeutics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Summit Therapeutics
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Biotechnology
About Summit Therapeutics
Funding Rounds & Investors (16)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Select | •••••• | 5 |
|
13 Feb 2025 |
| Post-IPO Equity | •••••• | - | 03 Jun 2024 | |
| Post-IPO Equity | •••••• | 2 | •••• •••• | 30 Jan 2023 |
| Post-IPO Equity | •••••• | - | 18 Jul 2022 | |
| Grant | •••••• | 1 |
|
18 May 2021 |
Latest News
View All
FAQ About Summit Therapeutics
Pioneering next-generation antibiotics for enhanced patient care and value in healthcare.
Summit Therapeutics was founded in 2003.
Summit Therapeutics operates in the following industries: Biotechnology, Health Care, Health and Wellness, Medical Devices.
Summit Therapeutics has approximately 51-200 employees.
Summit Therapeutics has completed 16 funding rounds, raising a total of $1.44B. The latest funding stage is Select.
Don't just browse. Track.
Signal Tracker monitors Summit Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.